Regulation And Legal
Aarey Drugs Clarifies PAT Mismatch in Q3 Results
Aarey Drugs submitted a clarification to NSE regarding a PAT figure mismatch in its Q3 FY26 results due to a clerical error.
The company has uploaded revised Integrated Financial Results with an ackno
